Diagnostics Biochem Canada receives Health Canada COVID-19 Medical Device Authorization for the sale of the DBC Anti-SARS-CoV-2 IgG ELISA Kit in Canada
The DBC Anti-SARS-CoV-2 IgG kit is a qualitative ELISA test intended for the detection of IgG antibodies to SARS-CoV-2 in
human serum or K2/K3 EDTA plasma from the adult population. The DBC Anti-SARS-CoV-2 IgG kit is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
The Anti-SARS-CoV-2 IgG ELISA kit is intended for use by trained laboratory personnel and is for laboratory use only.
Contact DBC for more information about this new kit, and how to order: